Pan-African healthcare technology company mPharma announced the launch of the mutti Keep My Price Program, which is for people who take long-term drugs.
After a successful pilot of the program, mPharma started the program with the goal of helping patients get their prescriptions at prices they can afford, even if prices on the market go up and down.
The new mPharma service will tackle the low supply chains
Supply chain systems have been disrupted As a result of the economic downturn, which has caused the prices of many goods and services to go up.
As a direct consequence of this, the prices of medications have gone up by as much as 30% at the wholesale level and by as much as 50% at the retail level, and because of this, mPharma started the Keep My Pricing initiative so that patients could get some price stability even though the economy is bad.
Read also: Vezeeta, healthcare platform obtains fresh capital for expansion
At the event where the initiative was introduced, Gregory Rockson, the Chief Executive Officer of mPharma, made the following statement: “An Africa in good health requires that patients are able to adhere to their medication, and that emphasizes the need for medication to be affordable.”
Over one thousand patients in Ghana were able to take advantage of the mutti Keep My Pricing Program, which gave them the opportunity to take advantage of a set price on their drugs for a period of three months.
Patients who signed up during the pilot phase got the same price for three months, no matter what happened to prices on the market as a whole during that time.
Mutti members can take advantage of the Keep My Price initiative, which has recently completed its rollout and is now fully operational. To sign up for the program, individuals can go to https://lnk.bio/mymutti, visit any of the mPharma pharmacies that are part of the mutti network, or phone 055 813 4375. Companies and insurance companies that are interested in participating in the program should contact mPharma by sending an email to info@mpharma.com.
mPharma also previously bought stake in HealthPlus
Additionally, mPharma had bought the majority ownership in HealthPlus, the most successful drugstore chain in Nigeria. A deal between mPharma and Alta Semper, mPharma’s previous investor, has been completed, and it will lead to the acquisition of a majority stake in the HealthPlus Group.
According to Gregory Rockson, the Chief Executive Officer and Co-founder of mPharma, the acquisition aligns with the company’s mission to build an Africa in good health by delivering life-changing healthcare services and drugs to improve the health outcomes for patients. mPharma’s mission is to build an African in good health by providing life-changing healthcare services and drugs. According to him, mPharma’s significant commitment to enhancing patient access to inexpensive and high-quality healthcare in Nigeria is complemented by the company’s recent acquisition of the HealthPlus Pharmacy chain.
54Gene uses AWS technology to enhance diversity in genomics research in Africa
About mPharma
It is a healthcare company driven by technology and focuses on the patient. They offer a variety of cutting-edge solutions, such as retail and primary care solutions for community pharmacies, vendor-managed inventory services, and data analytics. Its goal is to make Africa a healthier continent by ensuring access to medications for all patients at more affordable prices while simultaneously ensuring and protecting product quality. The company was established in 2013, and since then, it has expanded its operations to nine additional African nations, including Nigeria, Zambia, Kenya, Malawi, Rwanda, Ethiopia, Gabon, Togo, and Uganda. Our headquarters are located in Ghana. It currently has a network of over 400 pharmacies in its primary markets that collectively assist more than 100,000 patients monthly. its pharmacy partners have helped save the lives of millions of people in Africa by giving them life-saving medicines.
